We are live on ! Find out more
GC

GMT Capital Portfolio holdings

AUM $2.19B
1-Year Est. Return 72.3%
This Fund
S&P 500
This Quarter Est. Return
-5.03%
1 Year Est. Return
+72.3%
3 Year Est. Return
+172.46%
5 Year Est. Return
+183.05%
10 Year Est. Return
+942.8%
AUM
$2.66B
AUM Growth
+$12.7M
Cap. Flow
+$217M
Cap. Flow %
8.16%
Top 10 Hldgs %
53.68%
Holding
110
New
16
Increased
24
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
BBWI icon
Bath & Body Works
BBWI
+$56.8M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$39.1M
3
RPRX icon
Royalty Pharma
RPRX
+$27.6M
4
TSM icon
TSMC
TSM
+$22.8M
5
BABA icon
Alibaba
BABA
+$21M

Top Sells

Rank Stock Value
1
PVH icon
PVH
PVH
+$35.7M
2
SNX icon
TD Synnex
SNX
+$25.9M
3
BTG icon
B2Gold
BTG
+$22.1M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$17.4M
5
CMA
Comerica
CMA
+$14.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.6%
2 Materials 23.02%
3 Industrials 18%
4 Technology 10.21%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
26
Royalty Pharma
RPRX
$26.1B
$25.2M 0.95%
+929,700
New +$27.6M
FRPT icon
27
Freshpet
FRPT
$2.83B
$18.7M 0.7%
283,800
WBD icon
28
Warner Bros
WBD
$64.6B
$17.4M 0.65%
1,598,700
+819,169
+105% +$10.2M
GTE icon
29
Gran Tierra Energy
GTE
$260M
$17.3M 0.65%
2,488,831
GTX icon
30
Garrett Motion
GTX
$5.9B
$16.9M 0.64%
+2,145,882
New +$16.5M
PLTR icon
31
Palantir
PLTR
$295B
$16.3M 0.61%
1,017,400
KD icon
32
Kyndryl
KD
$2.66B
$14.6M 0.55%
+964,700
New +$14.3M
MRNS
33
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$13.9M 0.52%
1,722,695
+167,700
+11% +$1.39M
NAMS icon
34
NewAmsterdam Pharma
NAMS
$3.47B
$12.8M 0.48%
1,383,800
META icon
35
Meta Platforms (Facebook)
META
$1.51T
$11.7M 0.44%
39,000
-27,200
-41% -$8.2M
FSLY icon
36
Fastly Inc
FSLY
$3.17B
$11.5M 0.43%
598,800
BTG icon
37
B2Gold
BTG
$5.16B
$10.9M 0.41%
3,775,494
-6,790,600
-64% -$22.1M
NKLA
38
DELISTED
Nikola Corporation Common Stock
NKLA
$10.6M 0.4%
224,404
AMLX icon
39
Amylyx Pharmaceuticals
AMLX
$2.05B
$10.6M 0.4%
576,300
+115,300
+25% +$2.44M
PVH icon
40
PVH
PVH
$3.71B
$10.3M 0.39%
135,100
-431,700
-76% -$35.7M
MCHP icon
41
Microchip Technology
MCHP
$42.8B
$9.83M 0.37%
+126,000
New +$10.5M
ANF icon
42
Abercrombie & Fitch
ANF
$4.17B
$9.81M 0.37%
174,000
VTYX
43
DELISTED
Ventyx Biosciences
VTYX
$9.75M 0.37%
280,600
KLRS
44
Kalaris Therapeutics
KLRS
$88.7M
$9.05M 0.34%
183,099
+4,661
+3% +$318K
RCKT icon
45
Rocket Pharmaceuticals
RCKT
$348M
$8.43M 0.32%
411,200
-20,900
-5% -$380K
KNSA icon
46
Kiniksa Pharmaceuticals
KNSA
$4.83B
$8.3M 0.31%
477,853
+178,609
+60% +$3.01M
ANNX icon
47
Annexon
ANNX
$855M
$6.63M 0.25%
2,810,471
+345,900
+14% +$1.05M
NTR icon
48
Nutrien
NTR
$32.7B
$6.22M 0.23%
+100,700
New +$6.37M
OKTA icon
49
Okta
OKTA
$24.1B
$5.95M 0.22%
73,000
OM icon
50
Outset Medical
OM
$74.9M
$5.88M 0.22%
+36,052
New +$8.51M

Similar funds

GMT Capital's Q3 2023 Portfolio in Review

As of Q3 2023, GMT Capital held 110 positions worth $2.66B, up 0.48% from $2.64B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

GMT Capital deployed $217M of net new capital in Q3 2023, opening 16 new positions and adding to 24 existing holdings. Its largest new stake was iShares Semiconductor ETF: 234,930 shares worth $37.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 24% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was PVH, an estimated $35.7M trimmed.

  • GMT Capital's largest Q3 2023 buy was iShares Semiconductor ETF: 234,930 shares worth $37.1M.
  • GMT Capital added most to Bath & Body Works in Q3 2023, an estimated $56.8M increase.
  • GMT Capital's biggest Q3 2023 reduction was PVH, cutting an estimated $35.7M.
  • GMT Capital fully exited Comerica in Q3 2023, selling an estimated $14.6M.
  • GMT Capital's ten largest holdings make up 54% of its $2.66B portfolio in Q3 2023.
  • GMT Capital opened 16 new positions and closed 2 in Q3 2023.
  • GMT Capital's portfolio value rose 0.48% quarter-over-quarter to $2.66B.

Based on GMT Capital's 13F filing for Q3 2023, filed 13 Nov 2023.